Johnson & Johnson vs McCormick & Company
Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)
About
Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.
Hunt Valley MD global flavor leader (NYSE: MKC) at $6.72B FY2024 sales (+1%); McCormick/Old Bay/Frank's RedHot/French's brands, B2B Flavor Solutions for McDonald's and KFC, 2025 guidance 0-2% growth vs. Kraft Heinz.
About
McCormick & Company, Incorporated is a Hunt Valley, Maryland-based global leader in flavor — publicly traded on the New York Stock Exchange (NYSE: MKC for voting shares, MKC.V for non-voting shares) as an S&P 500 Consumer Staples component — manufacturing, marketing, and distributing spices, seasoning mixes, condiments, hot sauces, and flavor solutions under the McCormick, Lawry's, Old Bay, French's, Frank's RedHot, Stubb's, Club House, Kamis, and dozens of other branded and private label names through approximately 12,000 employees in 160 countries. In fiscal year 2024 (ending November 2024), McCormick reported net sales of $6.72 billion (+1%), adjusted EPS of $2.95, and a return to volume-led growth after two years of volume softness as consumers adjusted to post-pandemic spice price increases. For fiscal year 2025, McCormick guided 0-2% net sales growth and adjusted EPS of $3.03-$3.08, reflecting a cautious but positive outlook as consumer spending on branded flavor products stabilizes. CEO Brendan Foley, who assumed the role in 2023 (with founder-family member Lawrence Kurzius transitioning to Executive Chairman), focuses McCormick's strategy on global flavor leadership across two segments: Consumer (branded retail spices, seasonings, condiments — approximately 58% of revenue) and Flavor Solutions (B2B flavoring for foodservice chains and food manufacturing — approximately 42% of revenue). McCormick's B2B Flavor Solutions segment supplies the proprietary flavor packets and seasoning mixes used in fast food chains (McDonald's dipping sauces, KFC's Original Recipe flavor system) under undisclosed relationships that are embedded in customers' core product recipes.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.